Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Oxysophocarpine
Cat. No.:
0225LY-1141
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR, and HPLC.
Size:
Add to basket
Product Overview
Description:
Oxysophocarpine is a seaweed-derived alkaloid that provides antinociceptive and neuroprotective effects across the peripheral and central nervous systems.
Synonym:
26904-64-3; Matridin-15-one, 13,14-didehydro-, 1-oxide; (1R,2R,9S,13R,17S)-13-oxido-7-aza-13-azoniatetracyclo[7.7.1.02,7.013,17]heptadec-4-en-6-one; Sophocarpine N-oxide; (+)-oxysophocarpine
CAS No.:
26904-64-3
Compound CID:
24721085
Formula:
C15H22N2O2
Formula Weight:
262.35
Specification
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Oxysophocarpine can be used in hepatology research to examine its anti-fibrotic and anti-inflammatory properties in liver injury models.
Library Information
Target:
Prostaglandin receptor
Receptor:
PTGERs
Pathways:
GPCR/G protein signaling; Immunology/Inflammation
Plate Number:
AOCL-15
Plate Location:
f7
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10mM DMSO
DMSO Max Solubility:
50 mg/mL; 190.59 mM
Special Max Solubility:
DMSO:PBS (pH 7.2) (1:3): 0.25 mg/mL (0.63 mM), Sonication is recommended.
